Archives
-
Clasto-Lactacystin β-lactone in RIPK3 Biology
2026-08-24
Clasto-Lactacystin β-lactone offers a precise way to test whether proteasome activity connects viral immune evasion with RIPK3-driven necroptosis. This article translates landmark vIRD findings into a rigorous assay strategy while defining the compound’s handling, controls, and interpretive limits.
-
Birinapant (TL32711) and Apoptotic Thresholds in CRC
2026-08-24
Birinapant (TL32711) is a SMAC mimetic for dissecting IAP-controlled apoptosis and treatment resistance. This article presents a biomarker-aware assay framework connecting MDM1–p53 biology with cIAP/XIAP antagonism while separating established evidence from testable colorectal cancer hypotheses.
-
Light-Inducible RNA Release for Regulated Gene Therapy
2026-08-23
The reference study presents a rationally designed light-inducible RNA-releasing protein (LIRP) that controls therapeutic protein production at the translation stage rather than through transcriptional regulation. In vivo demonstrations in metabolic and retinal disease models show how light-accessible gene switches could provide reversible, tissue-compatible control of therapeutic transgenes, while also highlighting important translational constraints.
-
Paroxetine: Molecular Mechanisms and Research Implications
2026-08-22
The 2021 review by Kowalska and colleagues organizes paroxetine pharmacology around serotonin transporter inhibition while examining additional interactions with metabolic enzymes, kinases, and viral proteins. Its main practical contribution is a target-by-target framework that helps researchers distinguish established SSRI pharmacology from mechanistic hypotheses requiring orthogonal validation.
-
Indometacin Sodium: COX-2 and PSC Assay Logic
2026-08-22
Indometacin Sodium is more than a conventional COX inhibitor: it can function as a mechanistic perturbation for studying pancreatic stellate cell activation. This article translates published PSC findings into practical assay decisions, controls, and interpretation strategies for rigorous anti-inflammatory research.
-
Realgar CNS Toxicity and Ornithine–OTC Signaling
2026-08-21
A 2025 Advanced Science study identifies a liver–brain mechanism linking realgar-derived arsenic, hepatic OTC inhibition, ornithine accumulation, and ZBTB7A-dependent suppression of astrocyte glycolysis. Its integrated animal, cell, transcriptomic, metabolomic, behavioral, and histopathological design provides a framework for investigating how disrupted amino acid metabolism contributes to arsenic-related CNS injury.
-
Radiotherapy, PD-1/TIGIT Blockade, and Immune Memory
2026-08-20
The reference study shows that radiotherapy combined with PD-1 and TIGIT blockade can control both irradiated and distant tumors while generating durable CD8+ T-cell memory in several mouse models. Its integrated immune profiling identifies activated M1 macrophages and sustained cytokine signaling as important partners in the abscopal response, providing a mechanistic framework for combination cancer research.
-
Anti-HMGB1 Rabbit Monoclonal Antibody Guide
2026-08-20
Anti-HMGB1 Rabbit Monoclonal Antibody MA3057 supports research detection of HMGB1 in human, mouse, and rat samples by Western blot, immunohistochemistry, and flow cytometry. It is intended for controlled research workflows only, not diagnostic, therapeutic, or medical use, and assay-specific dilution and preparation conditions require laboratory optimization.
-
AZD8055: Practical mTOR Inhibitor Workflow
2026-08-19
AZD8055 is an ATP-competitive mTOR inhibitor for controlled studies of mTORC1 and mTORC2 signaling, cancer-cell proliferation, and selected metabolic endpoints. It is appropriate for preclinical mechanism-of-action workflows, but its poor aqueous solubility and limited clinical benefit make it unsuitable for studies centered on clinical efficacy or water-based dosing.
-
Estradiol Benzoate: ERα Assay Workflows
2026-08-19
Build reproducible estrogen receptor alpha assays with Estradiol Benzoate, from solvent-matched binding experiments to quantitative cell-signaling readouts. This guide emphasizes practical dosing, cross-species benchmarking, orthogonal validation, and troubleshooting rather than treating docking results as proof of biological activity.
-
Disulfiram Workflows for Cancer Research
2026-08-18
Disulfiram supports complementary cancer research workflows spanning ALDH2-linked synthetic lethality, ROS-driven apoptosis, and copper-associated proteasome inhibition. This practical guide connects APC-deficient colorectal cancer assays with established MDA-MB-231 proteasome studies while emphasizing formulation control and mechanism-specific troubleshooting.
-
a-MSH, Amide: From Melanogenesis to Translation
2026-08-18
A mechanistic and strategic guide to using a-MSH, amide as a controlled melanocortin challenge reagent for pigmentation regulation research, anti-inflammatory peptide research, and translational assay design.
-
Gramine for Ferroptosis Studies in TNBC
2026-08-17
Gramine is a practical ferroptosis inducer for connecting TNBC viability phenotypes with the CUL3–MTDH ubiquitination axis. This workflow covers stock preparation, dose-response design, target-engagement assays, rescue experiments, and troubleshooting for reproducible cancer biology research.
-
MOG (35-55) and Translational MS Strategy
2026-08-17
MOG (35-55) is more than an experimental autoimmune encephalomyelitis inducer: it is a controlled platform for connecting antigen-driven neuroinflammation with actionable signaling biology. This thought-leadership guide links model design, PARP7–STAT1/STAT2 findings, assay strategy, and translational decision-making for multiple sclerosis research.
-
Olsalazine and Organic Cation Transport in Aedes
2026-08-16
Kennel and Rouhier’s 2025 study examines how Aedes aegypti mosquitoes excrete three injected xenobiotics and whether exposure alters six putative organic cation transporter transcripts. Its central finding is a disconnect between relatively stable transporter mRNA profiles and strong chemical-structure-dependent changes in excretion and mortality, highlighting the need to study transporter function rather than expression alone.